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The EC-IC Bypass Study: Does it Answer the Question?

T

he procedure of cerebral revascularization was inttoduced
to the management of patients with cerebrovascular occlusive disease as a surgical option. Cerebral revascularization
is intended to reestablish cerebral perfusion to brain areas which
may be deficient in blood flow because of proximal arterial occlusive lesions. These lesions are not accessible by any other
surgical approach.
Cerebral revascularization was introduced in 1967 by Yasargil
and Donaghy (1), and many operations have since been performed. An intemational cooperative study (2,3) was designed
to determine whether the anastomosis of an extracranial to an
inttacranial artery (superficial temporal to middle cerebral artery STA-MCA) would be effective in reducing the development
of cerebral infarction or death in patients with otherwise inaccessible carotid circulation lesions. Patients who had been
symptomatic within three months before evaluation and who
had angiographically demonsttable lesions in the appropriate location were entered and randomized into either a medical group
receiving acetylsalicylic acid 325 mg four times a day throughout the trial or a surgical group undergoing an STA-MCA anastomosis in addition to the medication. A careful foUow-up was
completed for all these patients, and a commendable statistical
study was performed on the results.
The international cooperative study (2,3) found no demonstrable difference in the development of sttoke or death in patients treated either medically or surgically. In fact, in patients
with unilateral intemal carotid artery occlusion or with middle
cerebral artery stenosis, the patients in the surgical group had a
worse outcome. Conclusions of the study were: "...fatal and
nonfatal sttokes were not prevented by anastomosis ofthe superficial temporal to the middle cerebral artery... This negative result held for all patients and for individual subgroups, whether
the patients had transient ischemic attacks or minor strokes,
whether their lesions were occlusive or stenotic, and whether
they involved the intemal carotid artery, the middle cerebral artery or both."
The only scientific conclusion that can be made from the hypothesis tested in the extracranial-inttacranial bypass study is as
follows: EC-IC bypass surgery, primarily superficial temporal
to middle cerebral artery anastomosis, was not shown to reduce
sttoke or sttoke-related deaths more than the aspirin prescribed
for the population of patients selected, who were evaluated in the
manner detailed and analyzed with the methods described in the
study. No valid scientific conclusion can be made that the study
definitely proves bypass surgery to be of no value because the
hypothesis did not test that in the study.
We do not believe that the EC/IC bypass study has been specific enough to answer whether cerebral revascularization by
anastomosis ofthe superficial temporal artery to middle cerebral
artery effectively prevents cerebral infarction or death in patients with a demonsttated perfusion deficit referable to a spe-
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cific territory in the carotid circulation and who have an area of
inactive but viable cerebral tissue. Evidence from the study
would suggest that it contained a large percentage, probably
over 40% of its patients who in fact did not have a blood flow
deficit to the brain and who had no need for tiie surgery. Proponents of the study will argue that the study was based on the
methods of selection used by neurosurgeons who have published articles on the procedure claiming its benefit. This is tine
but relates to published work done in the past ten years. It does
not reflect the changing practice of those accomplished in the
procedure who no longer follow the indications upon which this
study was initially based. At present, these criteria have matured
to select those patients who are clinically unstable with continuing evidence of cerebral ischemia, with evidence of impaired
collateral circulation to the brain by examination of all the blood
vessels supplying the brain with four vessel cerebral angiography (the study required only two major vessels to be studied)
and by evaluation and selection of patients on the basis of cerebral blood flow testing.
The pathophysiological mechanisms responsible for the development of cerebral ischemia include: 1) an embolic process
from a distant source with the passage of artery to artery emboli
and the occlusion of a cerebral vessel, 2) a regional cerebral perfusion deficit that results from the existence of a proximal arterial occlusion or a hemodynamically significant stenosis, and
3) a local cerebral perfusion deficit secondary to the occlusion of
a small inttaparenchymal cerebral artery. Of these mechanisms,
the only one that could benefit from the procedure of cerebral
revascularization by an extracranial to intracranial anastomosis
is the perfusion deficit that results from a major proximal occlusive arterial lesion. Furthermore, not all proximal occlusive
lesions result in a perfusion deficit, and not all areas with decreased cerebral perfusion have viable tissue that would benefit
from a cerebral reconstmctive vascular procedure. The methodology in the EC/IC bypass study did not provide a means of
selection or separation of patients with a perfusion deficit who
have inactive yet viable tissue. Furthermore, the EC/IC bypass
study methods did not require full evaluation of coUateral circulation in patients entered in the smdy. The group reported that
" . . . bilateral common carotid arteriograms have been requested
on all patients, and angiography of the vertebrobasilar circulation has been optional" (3). Full understanding of the collateral
circulation to the area of occlusive disease cannot be gained
without a selective four-vessel cerebral angiogram.
The conttol group was treated with acetylsalicylic acid and
compared to the surgical group. The choice of medical treatment
was based on thefindingsof the Canadian Cooperative Study
Group (4), who compared the effect of aspirin, sulfinpyrazone,
and aspirin and sulfinpyrazone and placebo in patients who by
clinical criteria alone " . . . had experienced at least one cerebral
or retinal ischemic attack in the three months before entry."
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They reported a 19% reduction in the incidence of stroke or
sttoke-related deaths in a populationtteatedwith acetylsalicylic
acid 350 mg four times a day. The treatment was beneficial only
in men. When the four groups were analyzed individually, no
sufficient number of patients in any group benefited from the
tteatment to make a statistically valid conclusion. To gain statistical value, those patients tteated with aspirin alone and those
with aspirin and sulfinpyrazone were added, assuming that sulfinpyrazone had no effect whatsoever on thetteatment.Neither
the source of the symptoms nor the benefit of aspirin alone in
iv^ducing the incidence of sttoke or sttoke-related death in this
population were demonsttated.
Other aspirin studies have shown conflicting results. The
American, Italian, and Danish studies (5-7) showed no benefit
for patients treated with aspirin. The French aspirin study (8),
which included both men and women, found a benefit for patientstteatedwith aspirin. The benefit of aspirin in managing
patients with cerebral ischemic symptoms referable to specific
angiographic lesions in the carotid circulation has not been
demonsttated.
Three major premises in the EC/IC bypass study used to establish its statistical validity were "... a large number of patients
with a long period of follow-up,... a uniformity of disease process in the population studied,... and... the achievement of effective anastomoses
" The large number of patients was
reached through the collection of cases throughout the world
from 71 centers. An unproven assumption is that all people from
different parts of the world can be considered to have the same
behavior and can be treated equally when dealing with cerebrovascular occlusive disease. Furthermore, not all 71 centers
contributed the patients whom they saw to this study and thus a
certain preselection process occuned, leaving the study to evaluate a prescreened population of patients. Evidence from two of
the 71 centers involved alone indicates that over 90 patients in
those two centers were not included in the study. Since we could
not enter all of our patients in a consistent manner, we withdrew
early from the study.
Five groups or pattems of atherosclerotic carotid arterial disease were observed initially in the EC/IC bypass study: "isolated MCA stenosis, isolated MCA occlusion, isolated ICA stenosis (surgically inaccessible), isolated ICA occlusion, and
tandem lesions." When these groups were preserved as initially
presented, only the group with unilateral intemal carotid artery
occlusion had enough numbers to reach statistical power. In the
group's final report, the tandem lesion group was not mentioned,
and the numbers in all groups excluding the intemal carotid artery occlusion group were all different. Reported in the methodology was "when tandem lesions (two lesions in the same
vessel or sequence of vessels, one proximal to the other) have
existed, and both lesions have fulfilled entry criteria, the patient
has been entered for the most distal lesion" (3). Apparently, the
patients initially reported in the tandem group were later reallocated to the other groups based on the most distal lesion. Even
though this may be a statistically valid maneuver through which
all groups were brought to have enough numbers to reach statistical power, the assumption must be made for scientific acceptibility that patients with a single lesion have the same pathophysiological behavior as those patients with tandem lesions.

76 Henry Ford Hosp Med J—Vol 34, No 1, 1986

When these groups are combined, one can no longer assume that
the groups are uniform because other factors such as embolic
phenomena would not be equaUy distributed.
The achievement of effective anastomoses was determined by
a postoperative angiogram obtained "three to six months following bypass." However, the final functional status of the patients at the end of the study was not determined until five years
later This method assumes that the angiographic observations
made at the postoperative angiogram in the surgical group and in
the initial angiogram in the medical group have remained unchanged. Cerebrovascular occlusive disease is a dynamic process that caimot be expected to remain unchanged throughout
time. The final functional outcome, therefore, cannot be conelated with earlier angiographic procedures. Possibly other intervening occlusive events, different from those originally observed, developed in the interim. Without angiographic
conelation at the time of final evaluation, one cannot reach a
cause and effect conclusion.
The paper by Robertson et al (9) in this issue points out the
changes observed in a select population of patients with cerebral
ischemic events with full angiographic evaluation and with cerebral blood flow studies. The authors conclude that in this population " . . .STA-MCA bypass surgery is effective in increasing
CBF in a focal area of maximal ischemia."
It is unknown whether cerebral revascularization by anastomosis of the superficial temporal artery to the middle cerebral
artery prevents cerebral infarction or death in patients with a
demonsttated cerebral perfusion deficit and with viable residual
cerebral tissue in the area of ischemia. A randomized study must
be conducted to identify persons among the population with cerebral ischemic symptoms who have both a perfusion deficit and
preserved cerebral tissue. The random allocation to a surgical
and medical group with adequate follow-up by clinical, angiographic, blood flow, and metabolic criteria would then allow
one to determine the value of EC/IC bypass. Until then, the EC/
IC bypass smdy indicates that not all patients seen in the daily
clinical practice who have a unilateral intemal carotid or middle
cerebral artery occlusive lesion should be subjected to cerebral
revascularization. However, the EC/IC bypass study does not yet
exclude the value of cerebral revascularization for patients with a
focal cerebral perfusion deficit associated with viable cerebral
tissue. Furthermore, thefindingsof the EC/IC bypass study cannot be generalized to other bypass procedures such as proximal
MCA anastomosis or posterior fossa revascularization.
Fernando G. Diaz, MD, PhD
James I. Ausman, MD, PhD
Department of Neurosurgery
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